Enhances B Cell Responses in Type 2 Inflammation Through IL-17RB Receptor,” published in the January 2025 issue of Allergy ...

A phase 1 clinical trial co-led by researchers at Washington University School of Medicine in St. Louis found that a new type ...

A group of immune proteins called the inflammasome can help prevent blood stem cells from becoming malignant by removing ...

T-cell therapy, originally developed for haematological malignancies, has recently emerged as a promising therapy for ...

Researchers discovered that inflammasomes prevent cancer in blood stem cells by regulating proliferation and suppressing ...